Acute megakaryoblastic leukemia
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Acute megakaryoblastic leukemia Classification and external resources | |
| ICD-O: | M9910/3 |
|---|---|
| MeSH | D007947 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Acute megakaryoblastic leukemia (AMKL) is a form of leukemia where a majority of the blasts are megakaryoblastic.[1]
It is classified under M7 in the French-American-British classification.[1]
It is associated with GATA1, and risks are increased in individuals with Down syndrome.[1] However, not all cases are associated with Down syndrome,[1] and other genes can also be associated with AMKL.[1]
This category of AML is associate with 30% or more blasts in the marrow, blast are identified as being of megakaryocyte lineage by; Expression of megakaryocyte specific antigens and platelet peroxidase reaction on electron microscopy.
Signs and Symptoms
In adults include pancytopenia with low blast counts in the blood, myelofibrosis, an absence of lymphadenopathy and hepatosplenomegaly, poor response to chemptherapy,and short clinical course. In children; the same clinical presentation but with variable course especially in very young children; both leukocytosis and organomegaly may be present in children with M7. Complete remission and long term survival are more common in children than adults. In the first three of life megakaryoblastic leukemia is the most common type of leukemia in patients with Downs syndrome.[1]
Diagnosis
The morphology of cells was observed by means of bone marrow smear; the immunophenotype was detected by flow cytometry and immunohistochemistry assay.[1]
In blood and bone marrow smears megakaryoblasts are usually medium sized to large cells with a high nuclear- cytoplasmic ratio. Nuclear chromatin is dense and homogeneous. There is scanty, variable basophilic cytoplasm which may be vacuolated. An irregular cytoplasmic border is often noted in some of the megakaryoblasts and occasionally projections resembling budding atypical platelets are present. Megakaryoblasts lack myeloperoxidase activity and stain negatively with sudan black B. They are alpha naphthyl butyrate esterase negative and manifest variable alpha naphythyl acetate esterase activity usually in scattered clumps or granules in the cytoplasm. PAS staining also varies from negative to focal or granular positivity, to strongly positive staining. A marrow aspirate is difficult to obtain in many cases because of variable degree of myelofibrosis. More precise identification by immunophenotyping or with electron microscopy (EM). Immunophenotyping using MoAb to megakaryocyte restricted antigen (CD41 and CD61) may be diagnostic.[1]
References
External link
- http://www.meds.com/leukemia/flow/flow with flow cytometry in AML Atlas]
- Histology at University of Virginia
- Images at Nagoya University
WikiDoc Research Resources for Acute megakaryoblastic leukemia (Click show to right to view) | |
|---|---|
| Articles on Acute megakaryoblastic leukemia | Most recent articles on Acute megakaryoblastic leukemia • Most cited articles on Acute megakaryoblastic leukemia • Review articles on Acute megakaryoblastic leukemia • Articles on Acute megakaryoblastic leukemia in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Acute megakaryoblastic leukemia | Powerpoint slides on Acute megakaryoblastic leukemia • Images of Acute megakaryoblastic leukemia • Photos of Acute megakaryoblastic leukemia • Podcasts & MP3s on Acute megakaryoblastic leukemia • Videos on Acute megakaryoblastic leukemia |
| Evidence Based Medicine Regarding Acute megakaryoblastic leukemia | Cochrane Collaboration on Acute megakaryoblastic leukemia • Bandolier on Acute megakaryoblastic leukemia • TRIP on Acute megakaryoblastic leukemia |
| Cost Effectiveness of Acute megakaryoblastic leukemia | Cost Effectiveness of Acute megakaryoblastic leukemia |
| Clinical Trials Involving Acute megakaryoblastic leukemia | Ongoing Trials on Acute megakaryoblastic leukemia at Clinical Trials.gov • Trial results on Acute megakaryoblastic leukemia • Clinical Trials on Acute megakaryoblastic leukemia at Google |
| Guidelines / Policies / Government Resources (FDA/CDC) Regarding Acute megakaryoblastic leukemia | US National Guidelines Clearinghouse on Acute megakaryoblastic leukemia • NICE Guidance on Acute megakaryoblastic leukemia • NHS PRODIGY Guidance • FDA on Acute megakaryoblastic leukemia • CDC on Acute megakaryoblastic leukemia |
| Textbook Information on Acute megakaryoblastic leukemia | Books and Textbook Information on Acute megakaryoblastic leukemia |
| Pharmacology Resources on Acute megakaryoblastic leukemia | Dosing of Acute megakaryoblastic leukemia • Drug interactions with Acute megakaryoblastic leukemia • Side effects of Acute megakaryoblastic leukemia • Allergic reactions to Acute megakaryoblastic leukemia • Overdose information on Acute megakaryoblastic leukemia • Carcinogenicity information on Acute megakaryoblastic leukemia • Acute megakaryoblastic leukemia in pregnancy • Pharmacokinetics of Acute megakaryoblastic leukemia • |
| Genetics, Pharmacogenomics, and Proteinomics of Acute megakaryoblastic leukemia | Genetics of Acute megakaryoblastic leukemia • Pharmacogenomics of Acute megakaryoblastic leukemia • Proteomics of Acute megakaryoblastic leukemia |
| Newstories on Acute megakaryoblastic leukemia | Acute megakaryoblastic leukemia in the news • Be alerted to news on Acute megakaryoblastic leukemia • News trends on Acute megakaryoblastic leukemia |
| Commentary on Acute megakaryoblastic leukemia | Blogs on Acute megakaryoblastic leukemia |
| Patient Resources on Acute megakaryoblastic leukemia | Patient resources on Acute megakaryoblastic leukemia • Discussion groups on Acute megakaryoblastic leukemia • Patient Handouts on Acute megakaryoblastic leukemia • Directions to Hospitals Treating Acute megakaryoblastic leukemia • Risk calculators and risk factors for Acute megakaryoblastic leukemia |
| Healthcare Provider Resources on Acute megakaryoblastic leukemia | Symptoms of Acute megakaryoblastic leukemia • Causes & Risk Factors for Acute megakaryoblastic leukemia • Diagnostic studies for Acute megakaryoblastic leukemia • Treatment of Acute megakaryoblastic leukemia |
| Continuing Medical Education (CME) Programs on Acute megakaryoblastic leukemia | CME Programs on Acute megakaryoblastic leukemia |
| International Resources on Acute megakaryoblastic leukemia | Acute megakaryoblastic leukemia en Espanol • Acute megakaryoblastic leukemia en Francais |
| Business Resources on Acute megakaryoblastic leukemia | Acute megakaryoblastic leukemia in the Marketplace • Patents on Acute megakaryoblastic leukemia |
| Informatics Resources on Acute megakaryoblastic leukemia | List of terms related to Acute megakaryoblastic leukemia |
| ||||
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
